Optimizing Blood Pressure Control: A Randomized Comparative Trial of Losartan/Chlorthalidone vs. Losartan/Hydrochlorothiazide

Abstract Introduction Cardiovascular diseases are a leading cause of global mortality, with hypertension as a major risk factor. Low control rates are often attributed to monotherapy, while evidence and clinical guidelines support the effectiveness of combination therapies. This study aimed to evalu...

詳細記述

書誌詳細

主要な著者:	Isabel E. Rucker-Joerg, Ernesto G. Cardona-Muñoz, Francisco G. Padilla-Padilla, Rodrigo Suarez-Otero, Yulia Romero-Antonio, Emmanuel Canales-Vázquez, Kevin F. Rios-Brito, Ileana C. Rodríguez-Vazquez, Jorge González-Canudas
フォーマット:	Artigo
言語:	Inglês
出版事項:	Adis, Springer Healthcare 2025-04-01
シリーズ:	Cardiology and Therapy
主題:	Hypertension Cardiovascular disease Losartan Chlorthalidone Hydrochlorothiazide
オンライン･アクセス:	https://doi.org/10.1007/s40119-025-00407-7
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!